Evaluation of Inflammatory Markers, First‐Trimester Biochemical Tests, and Gelsolin Levels in Patients With Second‐Trimester Pregnancy Loss
American Journal of Reproductive Immunology · 2026-05 · 95 (5)
DOI: 10.1111/aji.70253 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, online erschienen am 05.05.2026. Verfasst von Betül Tokgöz Çakır und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Perinatology, Ankara Etlik City Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Gelsolin, Pregnancy Trimester, Second, Inflammation, Pregnancy Trimester, First. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Objective
The pathophysiological mechanisms underlying second trimester pregnancy loss are not yet fully elucidated. This study aimed to evaluate whether maternal serum gelsolin levels, together with hematological inflammatory indices and pregnancy related hormones, are associated with second trimester pregnancy loss.
Methods
A total of 912 pregnant women were prospectively enrolled, and a nested matched case‐control analysis was subsequently conducted including 112 participants (40 cases and 72 matched controls). The study was conducted at Ankara Etlik City Hospital between January and December 2024. The pregnancy loss group comprised 40 women who experienced second‐trimester pregnancy loss, whereas the control group included 72 age‐ and body mass index‐matched women with ongoing pregnancies. Maternal inflammatory markers—including the neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR), systemic inflammatory response index (SIRI), systemic immune–inflammation index (SII), and aggregate index of systemic inflammation (AISI)—were evaluated. In addition, serum levels of human chorionic gonadotropin (hCG), pregnancy‐associated plasma protein‐A (PAPP‐A), and gelsolin were measured and compared between groups.
Results
Most hematological inflammatory indices, including NLR, PLR, MLR, SII, SIRI, and AISI, did not differ significantly between the groups. However, maternal serum PAPP‐A levels were significantly lower in the pregnancy loss group ( p = 0.012), whereas gelsolin levels were significantly higher ( p = 0.034). Receiver operating characteristic (ROC) analysis demonstrated limited discriminatory performance for both markers. PAPP‐A MoM showed an AUC of 0.644 (95% CI: 0.533–0.755, p = 0.012), with a cut‐off value of 0.893 ng/mL.
Conclusion
Maternal serum gelsolin levels were elevated and PAPP‐A levels were reduced in pregnancies affected by second‐trimester pregnancy loss. While gelsolin remained independently associated with pregnancy loss after adjustment, neither marker demonstrated sufficient discriminatory performance to be used as a standalone predictive tool. These findings may reflect underlying placental dysfunction and inflammatory dysregulation rather than overt systemic inflammation, and should be considered hypothesis‐generating pending validation in larger prospective studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Perinatology, Ankara Etlik City Hospital, Ankara, Turkey.
- Department of Medical Genetics, Institute of Health Sciences, Başkent University, Ankara, Turkey.
- Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey.
ORCID-Profile: Betül Tokgöz Çakır, Gülşan Karabay, Nazan Vanlı Tonyalı, Zeynep Şeyhanlı, Dilara Duygulu Bulan, Kubilay Çanga, Hande Esra Koca Yıldırım, Ali Turhan Çağlar
Zitieren
APA
Çakır, B. T., Aktemur, G., Karabay, G., Tonyalı, N. V., Şeyhanlı, Z., Bulan, D. D., Çanga, K., Yıldırım, H. E. K., & Çağlar, A. T. (2026). Evaluation of Inflammatory Markers, First‐Trimester Biochemical Tests, and Gelsolin Levels in Patients With Second‐Trimester Pregnancy Loss. American Journal of Reproductive Immunology, 95(5). https://doi.org/10.1111/aji.70253
Vancouver
Çakır BT, Aktemur G, Karabay G, Tonyalı NV, Şeyhanlı Z, Bulan DD, et al. Evaluation of Inflammatory Markers, First‐Trimester Biochemical Tests, and Gelsolin Levels in Patients With Second‐Trimester Pregnancy Loss. American Journal of Reproductive Immunology. 2026;95(5). doi:10.1111/aji.70253
BibTeX
@article{akr2026,
author = {Çakır, Betül Tokgöz and Aktemur, Gizem and Karabay, Gülşan and Tonyalı, Nazan Vanlı and Şeyhanlı, Zeynep and Bulan, Dilara Duygulu and Çanga, Kubilay and Yıldırım, Hande Esra Koca and Çağlar, Ali Turhan},
title = {Evaluation of Inflammatory Markers, First‐Trimester Biochemical Tests, and Gelsolin Levels in Patients With Second‐Trimester Pregnancy Loss},
journal = {American Journal of Reproductive Immunology},
year = {2026},
volume = {95},
number = {5},
doi = {10.1111/aji.70253}
}
EUVIMED